STENTYS
Financial Information for the Third Quarter of 2019
Regulatory News:
STENTYS (Paris:STNT) (FR0010949404 — STNT), a French group specialized in medical technologies for interventional cardiology, today announced its quarterly revenues and consolidated cash position at September 30, 2019.
Revenues for the third quarter and first 9 months of 2019
€ thousands |
Q3 2019 |
Q3 2018 |
% change |
9M 2019 |
9M 20181 |
% change |
Europe2 |
930 |
1,164 |
-20% |
3,771 |
3,318 |
+14% |
Rest of the world |
403 |
1,105 |
-63% |
2,625 |
2,590 |
+1% |
Total revenues |
1,333 |
2,269 |
-41% |
6,396 |
5,908 |
+8% |
Lesen Sie auch
Audited data (except pro forma information)
€ thousands |
Q3 2019 |
Q3 2018 |
% change |
9M 2019 |
9M 20181 |
% change |
Stents |
501 |
1,416 |
-65% |
3,512 |
4,366 |
-20% |
Balloons & accessories |
832 |
853 |
-2% |
2,884 |
1,543 |
+87% |
Total revenues |
1,333 |
2,269 |
-41% |
6,396 |
5,908 |